⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9968485 | 0.85 | CYP2E1 (0.39) | — | |
| SCHEMBL14069820 | 0.84 | — | — | |
| SCHEMBL9964699 | 0.83 | MAOA (0.32) | — | |
| SCHEMBL9964705 | 0.80 | ACACB (0.31) | — | |
| SCHEMBL9964710 | 0.79 | MAOA (0.35) | — | |
| SCHEMBL9968486 | 0.78 | MAOA (0.40) | — | |
| SCHEMBL9968483 | 0.78 | MAOB (0.48) | — | |
| SCHEMBL14069821 | 0.77 | MAOA (0.40) | — | |
| SCHEMBL14069905 | 0.76 | CYP2E1 (0.31) | — | |
| SCHEMBL9964696 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
| WO-2008108988-A1 | ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS, INC. (US) | 2008-09-12 | — | — | WO | disclosed |